MedTrace Logo

Impact of Information About Booster Vaccination Against DTPolio at 25 Years on This Booster Vaccination's Realization

NCT04869735 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2125

Last updated 2021-07-06

No results posted yet for this study

Summary

The aim of vaccination is to protect the patient against disease by stimulating his immune system. DTPolio is a tetravalent vaccine providing protection against pertussis, diphtheria, tetanus and polio.

In France, the vaccination schedule sets the vaccination recommendations applicable to people according to their age. In this schedule, a booster of DTPolio at the age of 25 is recommended.

The vaccination coverage for patients over 16 years of age is insufficient in France.

Conditions

  • Vaccination

Interventions

OTHER

Data collection: DTPolio vaccine delivery

"with information about booster vaccination" group: Sending of information concerning booster vaccination against DTPolio at 25 years using letters, emails and SMS "without information about booster vaccination" group: no intervention

Sponsors & Collaborators

  • Université de Reims Champagne-Ardenne

    lead OTHER

Principal Investigators

  • Brigitte VUILLEMIN · Université de Reims CHampahne-Ardenne

Eligibility

Min Age
25 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-04
Primary Completion
2022-06-01
Completion
2022-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04869735 on ClinicalTrials.gov